Effects of estrogen against LPS-induced inflammation and toxicity in primary rat glial and neuronal cultures

Journal of Endotoxin Research

Volumn 13, Issue 3, 2007, Pages 158-166

  Tenenbaum, Meytal ^a   Azab, Abed N ^a   Kaplanski, Jacob ^a  

^a BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

Cytotoxicity; Estrogen; Inflammation; Neurodegeneration

Indexed keywords

ESTRADIOL; ESTROGEN; LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDE; NITRIC OXIDE; PROSTAGLANDIN E2; TUMOR NECROSIS FACTOR ALPHA; NITRITE;

ANIMAL CELL; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BRAIN NERVE CELL; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; CYTOTOXICITY TEST; EMBRYO; ENZYME LINKED IMMUNOSORBENT ASSAY; ESTROGEN ACTIVITY; GLIA CELL; INFLAMMATION; NERVE CELL CULTURE; NERVE DEGENERATION; NEUROPROTECTION; NEWBORN; NONHUMAN; RADIOIMMUNOASSAY; RAT; ANIMAL; BRAIN CORTEX; CELL CULTURE; CELL SURVIVAL; CHEMICALLY INDUCED DISORDER; CULTURE MEDIUM; CYTOLOGY; DOSE RESPONSE; DRUG EFFECT; GLIA; METABOLISM; NERVE CELL; TIME; WISTAR RAT;

RATTUS;

ANIMALS; ANIMALS, NEWBORN; CELL SURVIVAL; CELLS, CULTURED; CEREBRAL CORTEX; CULTURE MEDIA; DOSE-RESPONSE RELATIONSHIP, DRUG; ESTRADIOL; INFLAMMATION; L-LACTATE DEHYDROGENASE; LIPOPOLYSACCHARIDES; NEUROGLIA; NEURONS; NITRIC OXIDE; NITRITES; RATS; RATS, WISTAR; TIME FACTORS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 34548446441     PISSN: 09680519     EISSN: None     Source Type: Journal    
DOI: 10.1177/0968051907080428     Document Type: Article

References (60)

1. Aschner M. Immune and inflammatory responses in the CNS: Modulation by astrocytes. Toxicol Lett 1998; 102/103: 283-287.
2. Kreutzberg GW Microglia: A sensor for pathological events in the CNS. Trends Neurosci 1996; 19: 312-318.
3. Shemi D., Azab AN, Kaplanski J. Time-dependent effect of LPS on PGE2 and TNF-α production by ray glial brain culture: Influence of COX and cytokine inhibitors. J Endotoxin Res 2001; 6: 377-381.
4. Noble W., Planel E., Zehr C. et al. Inhibition of glycogen synthase kinase-3 by lithium correlates with reduced tauopathy and degeneration in vivo. Proc Natl Acad Sci USA 2005; 102: 6990-6995.
5. in't Veld BA, Ruitenberg A., Hofman A. et al. Nonsteroidal anti-inflammatory drugs and the risk of Alzheimer's disease. N Engl J Med 2001; 345: 1515-1521.
6. Liberatore GT, Jackson-Lewis V., Vukosaviz S. et al. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease. Nat Med 1999; 5: 1403-1409.
7. Gould TD, Zarate Jr CA, Manji HK. Glycogen kinase synthase-3: A target for novel bipolar disorder treatments. J Clin Psychiatry 2004; 65: 10-21.
8. O'Brien SM, Scully P., Scott LV, Dinan TG Cytokine profiles in bipolar affective disorder: Focus on actually ill patients. J Affect Disord 2006; 90: 263-267.
9. Cassano P., Hidalgo A., Burgos V., Adris S., Argibay P. Hippocampal upregulation of the cyclooxygenase-2 gene following neonatal clomipramine treatment (a model of depression). Pharmacogenom J. 2006; 6: 381-387.
10. Muller N., Schwarz MJ, Dehning S. et al. The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: Results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine. Mol Psychiatry 2006; 11: 680-684.
11. Muller N., Riedel M., Scheppach C. et al. Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia. Am J Psychiatry 2002; 159: 1029-1034.
12. Turrin NP, Rivest S. Innate immune reaction in response to seizures: implications for the neuropathology associated with epilepsy. Neurobiol Dis 2004; 16: 321 - 334.
13. Moncada S., Bolanos JP Nitric oxide, cell bioenergetics and neurodegeneration. J Neurochem 2006; 97: 1667-1689.
14. Smith WL, Garavito RM, DeWitt DL Prostaglandin endoperoxide H synthases (cyclooxygenases)-1 and -2. J Biol Chem 1996; 271: 33157-33160.
15. Smith WL, DeWitt DL, Garavito RM Cyclooxygenases: Structural, cellular, and molecular biology. Annu Rev Biochem 2000; 69: 145-182.
16. Wallace JL Selective COX-2 inhibitors: Is the water becoming muddy? Trends Pharmacol Sci 1999; 20: 4-6.
17. Coruzzi G., Menozzi A., Dobrilla G. Novel non-steroidal anti-inflammatory drugs: What we have learned from animal studies. Curr Drugs Targets Inflamm Allergy 2004; 3: 43-61.
18. Merrill JE, Murphy SP, Mitrovic B. et al. Inducible nitric oxide synthase and nitric oxide production by oligodendrocytes. J Neurosci Res 1997; 48: 372-384.
19. Knowles RG, Moncada S. Nitric oxide synthases in mammals. Biochem J 1994; 298: 249-258.
20. Vegeto E., Bonincontro C., Pollio G. et al. Estrogen prevents the lipopolysaccharide-induced inflammatory response in microglia. J Neurosci 2001; 27: 1809-1818.
21. Yue X., Lancaster T., Cao P. et al. Brain estrogen deficiency accelerates Aβ plaque formation in an Alzheimer's disease animal model. Proc Natl Acad Sci USA 2005; 102: 19198-19203.
22. Morale MC, Serra PA, L'Episcopo F. et al. Estrogen, neuroinflammation and neuroprotection in Parkinson's disease: Glia dictates resistance versus vulnerability to neurodegeneration. Neuroscienc 2006; 138: 869-878.
23. Vegeto E., Belcredito S., Ghisletti S., Meda C., Etteri S., Maggi A. The endogenous estrogen status regulates microglia reactivity in animal models of neuroinflammation. Endocrinology 2006; 147: 2263-2272.
24. Garcia-Segura LM, Naftolin F., Hutchison JB, Azcoitia I., Chowen JA Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. J Neurobiol 1999; 40: 574-584.
25. Toran-Allerand CD, Singh M., Setalo G. Novel mechanisms of estrogen action in the brain: New players in an old story. Front Neuroendocrinol 1999; 20: 97-121.
26. Alkayed NJ, Goto S., Sugo N. et al. Estrogen and Bcl-2: Gene induction and effect of transgene in experimental stroke. J Neurosci 2001; 21: 7543-7550.
27. Shi J., Panickar KS, Yang SH, Rabbani O., Day AL, Simpkins JW Estrogen attenuates over-expression of β-amyloid precursor protein messenger RNA in an animal model of focal ischemia. Brain Res 1998; 810: 87-92.
28. Gibbs RB, Hashash A., Johnson DA Effects of estrogen on potassium-stimulated acetylcholine release in the hippocampus and overlying cortex of adult rats. Brain Res 1997; 749: 143-146.
29. Yankova M., Hart SA, Woolley CS Estrogen increases synaptic connectivity between single presynaptic inputs and multiple postsynaptic CA1 pyramidal cells: A serial electron-microscopic study. Proc Natl Acad Sci USA 2001; 98: 3525-3530.
30. Siegfried T. It's all in the timing. Nature 2007; 445: 359-361.
31. Vaupel JW, Oeppen J. Broken limits to life expectancy. Science 2002; 296: 1029-1031.
32. Writing Group for the Women's Health Initiative Investigators. Risks and benefits of estrogen plus progestin in healthy postmenopausal women. JAMA 2002; 288: 321-333.
33. Li R., Shen Y., Yang LB, Lue LF, Finch C., Rogers J. Estrogen enhances uptake of amyloid beta-protein by microglia derived from the human cortex. J Neurochem 2000; 75: 1447-1454.
34. Atwood CS, Meethal SV, Liu T. et al. Dysregulation of the hypothalamic-pituitary-gonadal axis with menopause and andropause promotes neurodegenerative senescence. J Neuropathol Exp Neurol 2005; 64: 93-103.
35. Xu H., Gouras GK, Greenfield JP et al. Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides. Nat Med 1998; 4: 447-451.
36. Paganini-Hill A., Henderson VW Estrogen replacement therapy and risk of Alzheimer disease. Arch Intern Med 1996; 156: 2213-2217.
37. Shumaker SA, Legault C., Rapp SR et al. Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women. JAMA 2002; 288: 321-333.
38. Henderson VW Estrogen-containing hormone therapy and Alzheimer's disease risk: Understanding discrepant inferences from observational and experimental research. Neuroscience 2006; 138: 1031-1309.
39. Morrison JH, Brinton RD, Schmidt PJ, Gore AC Estrogen, menopause, and the aging brain: How basic neuroscience can inform hormone therapy in women. J Neurosci 2006; 26: 10332-10348.
40. Sribnick EA, Wingrave JM, Matzelle DD, Wilford GG, Ray SK, Banik NL Estrogen attenuated markers of inflammation and decreased lesion volume in acute spinal cord injury in rats. J Neurosci Res 2005; 82: 283-293.
41. Wise PM Estrogen therapy: Does it help or hurt the adult and aging brain? Insights derived from animal models. Neuroscience 2006; 138: 831-835.
42. Chudasama Y., Robbins TW Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans. Biol Psychol 2006; 73: 19-38.
43. Coyle JT, Price DL, Delong MR Alzheimer's disease: A disorder of cortical cholinergic innervation. Science 1983; 219: 1184-1190.
44. Meberg PJ, Miller MW Culturing hippocampal and cortical neurons. Methods Cell Biol 2003; 71: 111-127.
45. Azab AN, Kaplanski J. Involvement of eicosanoids in the hypothermic response to lipopolysaccharide during endotoxemia in rats. Prostaglandins Leukot Essent Fatty Acids 2004; 70: 67-75.
46. Green LC, Wagner DA, Glogowski J., Skipper PL, Wishnok JS, Tannenbaum SR Analysis of nitrate, nitrite, and [15N]-nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
47. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ Protein measurement with the Folin phenol reagent. J Biol Chem 1951; 193: 265-275.
48. Baumann H., Gauldie J. The acute phase response. Immunol Today 1994; 15: 74- 80.
49. Bamberger ME, Landreth GE Inflammation, apoptosis, and Alzheimer's disease. Neuroscientist 2002; 8: 276-283.
50. McGeer EG, McGeer PL Inflammatory processes in Alzheimer's disease. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 741-749.
51. Hayashi T., Yamada K., Esaki T., Muto E., Chaudhuri G., Iguchi A. Physiological concentrations of 17beta-estradiol inhibit the synthesis of nitric oxide synthase in macrophages via a receptor-mediated system. J Cardiovasc Pharmacol 1998; 31: 292 - 298.
52. Zancan V., Santagati S., Bolego C., Vegeto E., Maggi A., Puglisi L. 17Beta-estradiol decreases nitric oxide synthase II synthesis in vascular smooth muscle cells. Endocrinology 1999; 140: 2004-2009.
53. Barone FC, Arvin B., White RF et al. Tumor necrosis factor-alpha. A mediator of focal ischemic brain injury. Stroke 1997; 28: 1233-1244.
54. Viviani B., Corsini E., Galli CL, Marinovich M. Glia increase degeneration of hippocampal neurons through release of tumor necrosis factor-alpha. Toxicol Appl Pharmacol 1998; 150: 271-276.
55. 2+ signals and neuronal death in brain ischemia. Stroke 2007; 38: 674-676.
56. Meldrum B., Garthwaite J. Excitatory amino acid neurotoxicity and neurodegenerative disease. Trends Pharmacol Sci 1990; 11: 379-387.
57. Goodman Y., Bruce AJ, Cheng B., Mattson MP Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid beta-peptide toxicity in hippocampal neurons. J Neurochem 1996; 66: 1836 - 1844.
58. Honda K., Sawada H., Kihara T. et al. Phosphatidylinositol 3-kinase mediates neuroprotection by estrogen in cultured cortical neurons. J Neurosci Res 2000; 60: 321-327.
59. Dhandapani K., Brann D. Neuroprotective effects of estrogen and tamoxifen in vitro: A facilitative role for glia? Endocrine 2003; 21: 59-66.
60. Sortino MA, Chisari M., Merlo S. et al. Glia mediates the neuroprotective action of estradiol on beta-amyloid-induced neuronal death. Endocrinology 2004; 145: 5080-5086.